Skip to main content
Acta Pharmacologica Sinica logoLink to Acta Pharmacologica Sinica
. 2023 Aug 4;44(12):2550. doi: 10.1038/s41401-023-01132-4

Author Correction: Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibition

Kai-long Jiang 1,2,3,4,5, Chang-mei Liu 3,6, Li-tong Nie 3, Hai-ni Jiang 2,7, Lei Xu 2,3, Kun-zhi Zhang 3,8, Li-xia Fan 3, An-hui Gao 3, Lu-lin Lin 1, Xiang-yu Wang 5, Min-jia Tan 3, Qi-qing Zhang 1,, Yu-bo Zhou 2,3,4,, Jia Li 2,3,4,7,9,
PMCID: PMC10692070  PMID: 37542201

Correction to: Acta Pharmacologica Sinica 10.1038/s41401-022-00949-9, published online 15 July 2022

The authors are very sorry for two mistakes in the spelling of two authors’ names among the listed co-authors: The 9th author “Lu-ling Lin” and 11th author “Ming-jia Tan” were spelled incorrectly, and the correct spelling should be “Lu-lin Lin” and “Min-jia Tan”. These errors were made completely by accident, due to our negligence. The authors apologize for any inconvenience caused to the Journal and readers.

Contributor Information

Qi-qing Zhang, Email: zhang.qiqing@szhospital.com.

Yu-bo Zhou, Email: ybzhou@simm.ac.cn.

Jia Li, Email: jli@simm.ac.cn.


Articles from Acta Pharmacologica Sinica are provided here courtesy of Nature Publishing Group

RESOURCES